Health Protection Agency: White Papers

HPA Case Study: Analytical Method Development
Monday, December 19, 2011 by Health Protection Agency Regulatory authorities are increasingly placing greater emphasis on analytical methods in manufacturing. This is particularly so with biopharmaceuticals where the requirement is often for a...

HPA Case Study: Development of a Manufacturing Process for a Biodefence Vaccine
Monday, December 19, 2011 by Health Protection Agency The Process & Analytical Development Group (PADG) has recently completed the final development of a manufacturing process for an important biodefence vaccine on behalf of a US...

HPA Case Study: Production of Non-GMP Biologicals
Monday, December 19, 2011 by Health Protection Agency The Process & Analytical Development Group has supplied a variety of customers with a broad range of microbial products. Our expertise in protein analysis and enzymology mean that our products...

HPA Case Study: Technical Support for FDA Licensure of Erwinaze™
Monday, December 19, 2011 by Health Protection Agency Erwinaze™, a biotherapeutic used for the treatment of acute lymphoblastic leukemia (ALL), is manufactured by the HPA in its cGMP facilities at Porton Down and is currently distributed to over...